Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Thallion Pharmaceutiques Inc.
Woman and Man
Between 18 years
and 99 years
Thallion Pharmaceutiques Inc.
Update Il y a 4 ans
Thallion CTP_CAP001 : Essai de phase 2 évaluant l’efficacité et la tolérance du CAP-232 chez des patients ayant un cancer du rein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A multi-centre, open label, phase II study of the safety, efficacy and pharmacokinetic (PK) profile of CAP-232 administered through continuous intravenous infusion in patients with metastatic kidney c...
Country
France
organs
Rein
Specialty
Chimiothérapie
Essai clos aux inclusions
More information